Medical tests

The veterinary monitoring equipment market is projected to reach USD 570 million by 2025 from USD 326 million in 2019, at a CAGR of 9.8%

Friday, May 29, 2020 - 4:30pm

The veterinary monitoring equipment market is projected to reach USD 570 million by 2025 from USD 326 million in 2019, at a CAGR of 9.8%.

Key Points: 
  • The veterinary monitoring equipment market is projected to reach USD 570 million by 2025 from USD 326 million in 2019, at a CAGR of 9.8%.
  • On the basis of type, the veterinary monitoring equipment market segmented into vital sign monitors, anesthesia monitors, capnography & oximetry systems, ECG & EKG monitors, MRI systems, and other equipment.The vital sign monitors segment is projected to witness the highest growth in the veterinary monitoring equipment market during the forecast period.
  • A breakdown of the primary participants referred to for this report is provided below:
    The prominent players in the veterinary monitoring equipment market are Smiths Group plc.
  • The report analyzes the market for various veterinary monitoring equipment and their adoption patterns.It aims at estimating the market size and future growth potential of the veterinary monitoring equipment market and its subsegments.

InfoMart Releases Background Screening Solutions Designed for Remote & Reentering Workforces

Thursday, May 28, 2020 - 1:00pm

While HR departments around the world manage the impact of COVID-19 on their workforces and employment policies, InfoMart has created background screening solutions designed for remote team management, employees returning to physical offices, and hiring best practices for this new way of onboarding.

Key Points: 
  • While HR departments around the world manage the impact of COVID-19 on their workforces and employment policies, InfoMart has created background screening solutions designed for remote team management, employees returning to physical offices, and hiring best practices for this new way of onboarding.
  • This initial rollout of their New World of Work Screening Suite delivers accurate background check results at industry-leading speeds and provides a fully remote candidate experience to protect every member of your team.
  • "We are in the business of keeping employees and companies safe, and we immediately recognized the need for remote background screening solutions that responded to our current reality," continued Cohen.
  • To learn more about InfoMart and their New World of Work Screening Suite, reach out today or contact Sales(at)InfoMart-USA(dot)com.

Novagen Is Proud to Offer Top DNA Testing Services for The People of Vietnam

Tuesday, May 26, 2020 - 3:00pm

DNA testing is the process of verifying a blood relationship between two people by comparing specific DNA markers in each person's genome.

Key Points: 
  • DNA testing is the process of verifying a blood relationship between two people by comparing specific DNA markers in each person's genome.
  • Novagen is offering DNA testing services that focus on gene identification services, DNA testing, prenatal DNA testing, genetic testing and NIPT noninvasive prenatal screening.
  • The Novagen testing laboratory is meeting the ISO 9001: 2015 standard and is the first company to apply 27 loci testing technology in DNA testing.
  • Customers of Novagen can access various types of testing and services such as DNA tests for father and son, DNA test for the birth certificate, DNA tests for illegitimate son, prenatal DNA test, non-invasive fetal DNA test , DNA tests for mother and children, DNA testing for Bowel DNA, DNA tests for grandparents and grandchildren, DNA tests for relatives, screening for non-invasive birth defects, sequencing of new generation NGS gene.

Data at 2020 ASCO Virtual Scientific Program Demonstrates Strength of Nucleix’s Six-Marker Methylation-Based Assay Detecting Broad Array of Early Cancers

Tuesday, May 26, 2020 - 2:00pm

The six-marker assay serves as an initial component of Nucleixs screening tests generating significant signal in early cancers and leveraging existing, low-cost PCR technology.

Key Points: 
  • The six-marker assay serves as an initial component of Nucleixs screening tests generating significant signal in early cancers and leveraging existing, low-cost PCR technology.
  • We look forward to sharing updates on the promising data supporting our Lung EpiCheck for patients at high risk for lung cancer.
  • We are building an EpiCheck franchise, beginning with our Bladder EpiCheck testing kit marketed in Europe for bladder cancer recurrence.
  • We are advancing a Lung EpiCheck test toward commercialization for high-risk individuals, while advancing additional tests for high-risk diseases.

Backwoods Security Services Launches Thermal Temperature Screening Service: TempScout

Tuesday, May 26, 2020 - 2:00pm

TempScout is a comprehensive service that makes mass temperature screening accessible for any workplace seeking to enhance its health and safety standards.

Key Points: 
  • TempScout is a comprehensive service that makes mass temperature screening accessible for any workplace seeking to enhance its health and safety standards.
  • TempScout services can be scaled and tailored to any business size or location by offering mass temperature screening, networked scanning solutions and stand-alone scanning options.
  • Backwoods Security Services, a division of Backwoods Energy Services, has been concerned with the protection and wellbeing of people since 1986.
  • Backwoods Security Services solutions include site-wide emergency response, mass temperature screening, mobile surveillance units, accident scene support and more.

Global Rapid Influenza Diagnostic Tests Market (2020 to 2024) - Featuring Abbott Laboratories, bioMerieux & Bio-Rad Laboratories Among Others - ResearchAndMarkets.com

Tuesday, May 26, 2020 - 12:53pm

The "Global Rapid Influenza Diagnostic Tests Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Rapid Influenza Diagnostic Tests Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
  • The rapid influenza diagnostic tests market is poised to grow by USD 0.89 billion during 2020-2024 progressing at a CAGR of 11% during the forecast period.
  • The reports on rapid influenza diagnostic tests market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • This study identifies the rising technological advancements in diagnostics as one of the prime reasons driving the rapid influenza diagnostic tests market growth during the next few years.

Accurate Diagnostic Laboratories Continues to Assist Our Front-Line Workers by Offering Coronavirus Testing for Port Authority/PATH Essential Employees

Thursday, May 21, 2020 - 11:17pm

"Our commitment to our frontline and essential workers has been ingrained in our efforts from the beginning of this pandemic," says Rupen Patel, CEO of Accurate Diagnostic Labs.

Key Points: 
  • "Our commitment to our frontline and essential workers has been ingrained in our efforts from the beginning of this pandemic," says Rupen Patel, CEO of Accurate Diagnostic Labs.
  • Earlier this month, Accurate Diagnostic Labs, in collaboration with RUCDR, expanded their COVID-19 testing options by launching the first SARS-CoV-2 saliva test cleared for at-home collection by the FDA through Emergency Use Authorization (EUA).
  • Accurate Diagnostic Labs also recently launched serology antibody testing to meet the needs of laboratory testing for the population that may have already been infected with the virus.
  • About Accurate Diagnostic Labs: Accurate Diagnostic Labs is one of the largest privately held, boutique, full-service clinical laboratories in the Northeast.

New Report Profiles Over 90 Significant Competitors in Point-of-Care Testing

Thursday, May 21, 2020 - 11:00am

90 other point of test companies are profiled in the report.

Key Points: 
  • 90 other point of test companies are profiled in the report.
  • Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests.
  • There are also many small, portable instruments that have been developed for use in POC settings.
  • The traditional set of POC tests includes blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening.

NorthShore provides real time genomic decision support to 10,000 patients using the ActX Service

Thursday, May 21, 2020 - 11:00am

In 2016, they implemented ActX Genomic Decision Support inside Epic.

Key Points: 
  • In 2016, they implemented ActX Genomic Decision Support inside Epic.
  • NorthShore has taken an additional 10,000 patients through genetic testing as part of the DNA-10K initiative.
  • Our service helps physicians make better decisions about medical treatment, using a patient's genetic information to guide therapy.
  • The ActX Genomic Service offers proven, tightly integrated, real-time genomic decision support for medication orders and actionable genomic risks, a built in patient Genomic Profile, and the ability to fully customize content.

Molecular Diagnostics Market Study 2019-2029 Featuring Profiles of 268 Companies along with 657 Collaborations

Wednesday, May 20, 2020 - 4:00pm

The most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics.

Key Points: 
  • The most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics.
  • Includes profiles of 268 companies, the largest number in any report on this topic.
  • More than 1,000 companies have been identified to be involved in developing molecular diagnostics and 268 of these are profiled in the report along with tabulation of 657 collaborations.
  • A new edition in 1997 "Molecular Diagnostics I" as well as the next edition, "Molecular Diagnostics II" in 1999, were published by Decision Resources Inc, USA.